What were Health X Platform Ltd's latest quarterly results?
Health X Platform Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -172.2% (stable)
- Revenue Growth YoY: +30.8%
- Operating Margin: -7.0% (volatile)
Health X Platform Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +15.2%WeakRe-Entry
In , Health X Platform Ltd (Pharmacy Distribution) is outperforming Nifty 500 with +15.2% relative strength. Fundamentals: Weak.
Health X Platform Ltd Key Facts
- PE Ratio
- 536.0x
- Market Cap
- ₹1,028 Cr
- PAT Growth YoY
- -172%
- Revenue Growth YoY
- +31%
- OPM
- -7.0%
- RS vs Nifty 500
- +15.2%
Riding Wave
What's Happening
💪Debt reduced 81% YoY — balance sheet strengthening
🌐FII stake increased 1.1% this quarter
💰Trading 96% above estimated fair value — significant premium
Key Numbers
PAT Growth YoY
-172%
Stable
Revenue YoY
+31%
Stable
Operating Margin
-7.0%
+200 bps YoY
PE Ratio
536.0
Current Price
₹323
Fundamental Score
27/100
Weak
3Y PAT CAGR
+80%
Market Cap
1.0K Cr
Valuation
Significantly Overvalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Health X Platform Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +31% | +8% | Stable |
| PAT (Net Profit) | -172% | +80% | Stable |
| OPM | -7.0% | +200 bps | Volatile |
Frequently Asked Questions: Health X Platform Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Health X Platform Ltd's profit growing or declining?
Health X Platform Ltd's profit is declining with a stable trend.
- PAT Growth YoY: -172.2% (latest quarter)
- 3-Year PAT CAGR: +80.0%
- Trend: Stable — consistent growth pattern
What is Health X Platform Ltd's revenue growth trend?
Health X Platform Ltd's revenue growth trend is stable.
- Revenue Growth YoY: +30.8%
- Revenue Growth QoQ: +8.1% (sequential)
- 3-Year Revenue CAGR: +7.6%
How is Health X Platform Ltd's operating margin trending?
Health X Platform Ltd's operating margin is volatile.
- Current OPM: -7.0%
- OPM Change YoY: +2.0% basis points
- OPM Change QoQ: -4.0% basis points
What is Health X Platform Ltd's 3-year profit and revenue CAGR?
Health X Platform Ltd's long-term compounding rates
- 3-Year Profit CAGR: +80.0%
- 3-Year Revenue CAGR: +7.6%
Is Health X Platform Ltd's growth accelerating or decelerating?
Health X Platform Ltd's earnings growth is stable with insufficient data on a sequential basis.
- YoY Acceleration: -180.0% bps
What is Health X Platform Ltd's trailing twelve month (TTM) performance?
Health X Platform Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹-1 Cr
- TTM PAT Growth: +99.3% YoY
- TTM Revenue: ₹1,000 Cr
- TTM Revenue Growth: +18.7% YoY
- TTM Operating Margin: -4.2%
Is Health X Platform Ltd overvalued or undervalued?
Health X Platform Ltd appears significantly overvalued based on our fair value analysis.
- Valuation Signal: Significantly Overvalued
- Current PE: 536.0x
- Price-to-Book: 1.6x
What is Health X Platform Ltd's current PE ratio?
Health X Platform Ltd's current PE ratio is 536.0x.
- Current PE: 536.0x
- Market Cap: 1.0K Cr
How does Health X Platform Ltd's valuation compare to its history?
Health X Platform Ltd's current PE is 536.0x.
- Current PE: 536.0x
- Valuation Assessment: Significantly Overvalued
What is Health X Platform Ltd's price-to-book ratio?
Health X Platform Ltd's price-to-book ratio is 1.6x.
- Price-to-Book (P/B): 1.6x
- Book Value per Share: ₹201
- Current Price: ₹323
Is Health X Platform Ltd a fundamentally strong company?
Health X Platform Ltd is rated Weak with a fundamental score of 27.08/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +30.8% (10% weight)
- PAT Growth YoY: -172.2% (10% weight)
- Margins stable (10% weight)
Is Health X Platform Ltd debt free?
Health X Platform Ltd's debt position
- Total Debt: ₹26 Cr
What is Health X Platform Ltd's return on equity (ROE) and ROCE?
Health X Platform Ltd's return ratios over recent years
- FY2024: ROCE -3.0%
- FY2025: ROCE -1.0%
- FY2026: ROCE 0.0%
Is Health X Platform Ltd's cash flow positive?
Health X Platform Ltd's operating cash flow is negative (FY2026).
- Cash from Operations (CFO): ₹-74 Cr
- Free Cash Flow (FCF): ₹97 Cr
What is Health X Platform Ltd's dividend yield?
Health X Platform Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹323
Who holds Health X Platform Ltd shares — promoters, FII, DII?
Health X Platform Ltd's shareholding pattern (Mar 2026)
- Promoters: 74.8%
- FII (Foreign): 2.2%
- DII (Domestic): 2.6%
- Public: 20.4%
Is promoter holding increasing or decreasing in Health X Platform Ltd?
Health X Platform Ltd's promoter holding has increased recently.
- Current Promoter Holding: 74.8% (Mar 2026)
- Previous Quarter: 74.7% (Dec 2025)
- Change: +0.15% (increasing — positive signal)
How long has Health X Platform Ltd been outperforming Nifty 500?
Health X Platform Ltd has been outperforming Nifty 500 for 2 consecutive weeks, indicating early-stage outperformance.
Is Health X Platform Ltd a new momentum entry or an established outperformer?
Health X Platform Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.
Is Health X Platform Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Health X Platform Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Health X Platform Ltd?
Health X Platform Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +30.8% YoY
Risk Factors (Bear Case)
- Appears significantly overvalued
What is the future outlook for Health X Platform Ltd?
Health X Platform Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: stable
- Margin Trend: volatile
- Valuation: Significantly Overvalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.